Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Q Chen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of the American Association for Laboratory Animal Science : JAALAS|September 23, 2010
Assessment of carprofen and buprenorphine on recovery of mice after surgical removal of the mammary fat padTrinka W Adamson, Lon V Kendall, Sherri Goss, et al.
Disease Models & Mechanisms|May 8, 2012
Initiation of prostate cancer in mice by Tp53R270H: evidence for an alternative molecular progressionRuth L Vinall, Jane Q Chen, Neil E Hubbard, et al.
Breast Cancer Research : BCR|September 4, 2017
Pathobiology of the 129:Stat1 <sup>-/-</sup> mouse model of human age-related ER-positive breast cancer with an immune infiltrate-excluded phenotypeHidetoshi Mori, Jane Q Chen, Robert D Cardiff, et al.
Journal for Immunotherapy of Cancer|April 22, 2017
Differential phenotypes of memory CD4 and CD8 T cells in the spleen and peripheral tissues following immunostimulatory therapyGail D Sckisel, Annie Mirsoian, Christine M Minnar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2010
Longitudinal investigation of permeability and distribution of macromolecules in mouse malignant transformation using PETCecilie B Rygh, Shengping Qin, Jai W Seo, et al.
The Journal of Biological Chemistry|May 23, 2013
An integrin binding-defective mutant of insulin-like growth factor-1 (R36E/R37E IGF1) acts as a dominant-negative antagonist of the IGF1 receptor (IGF1R) and suppresses tumorigenesis but still binds to IGF1RMasaaki Fujita, Katsuaki Ieguchi, Dora M Cedano-Prieto, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 13, 2013
Quantitation of fixative-induced morphologic and antigenic variation in mouse and human breast cancersRobert D Cardiff, Neil E Hubbard, Jesse A Engelberg, et al.
Plos One|June 16, 2015
Abnormal Mammary Development in 129:STAT1-Null Mice is Stroma-DependentJane Q Chen, Hidetoshi Mori, Robert D Cardiff, et al.
Molecular Cancer Research : MCR|June 16, 2021
HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic PhaseJoshua D Ginzel, Chaitanya R Acharya, Veronica Lubkov, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of the American Association for Laboratory Animal Science : JAALAS|September 23, 2010
Assessment of carprofen and buprenorphine on recovery of mice after surgical removal of the mammary fat padTrinka W Adamson, Lon V Kendall, Sherri Goss, et al.
Disease Models & Mechanisms|May 8, 2012
Initiation of prostate cancer in mice by Tp53R270H: evidence for an alternative molecular progressionRuth L Vinall, Jane Q Chen, Neil E Hubbard, et al.
Breast Cancer Research : BCR|September 4, 2017
Pathobiology of the 129:Stat1 <sup>-/-</sup> mouse model of human age-related ER-positive breast cancer with an immune infiltrate-excluded phenotypeHidetoshi Mori, Jane Q Chen, Robert D Cardiff, et al.
Journal for Immunotherapy of Cancer|April 22, 2017
Differential phenotypes of memory CD4 and CD8 T cells in the spleen and peripheral tissues following immunostimulatory therapyGail D Sckisel, Annie Mirsoian, Christine M Minnar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2010
Longitudinal investigation of permeability and distribution of macromolecules in mouse malignant transformation using PETCecilie B Rygh, Shengping Qin, Jai W Seo, et al.
The Journal of Biological Chemistry|May 23, 2013
An integrin binding-defective mutant of insulin-like growth factor-1 (R36E/R37E IGF1) acts as a dominant-negative antagonist of the IGF1 receptor (IGF1R) and suppresses tumorigenesis but still binds to IGF1RMasaaki Fujita, Katsuaki Ieguchi, Dora M Cedano-Prieto, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 13, 2013
Quantitation of fixative-induced morphologic and antigenic variation in mouse and human breast cancersRobert D Cardiff, Neil E Hubbard, Jesse A Engelberg, et al.
Plos One|June 16, 2015
Abnormal Mammary Development in 129:STAT1-Null Mice is Stroma-DependentJane Q Chen, Hidetoshi Mori, Robert D Cardiff, et al.
Molecular Cancer Research : MCR|June 16, 2021
HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic PhaseJoshua D Ginzel, Chaitanya R Acharya, Veronica Lubkov, et al.
Pageof 1